For 80 years the Department of Psychiatry has provided the highest quality care to adults, children and adolescents, along with pioneering research and education.
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital today announced topline results from Regimen F of the HEALEY ALS Platform Trial evaluating fosigotifator (ABBV-CLS-7262) in people living with amyotrophic lateral sclerosis (ALS).
Researchers found that genetic swaps in the gut microbiome are occurring much more frequently than previously thought and detected more than 100,000 swaps that hadn’t been seen before.
University of Minnesota, Essentia Health Dose First Participants in Sean M. Healey & AMG Center for ALS, Never Surrender Inc. Led Expanded Access Protocol Programs
Dan G. Duda, DMD, PhD, is the corresponding author of a paper published in Cancer Immunology Research, “Combination CXCR4 and PD1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma.”
Shadmehr (Shawn) Demehri, MD, PhD, is the corresponding author of a paper published in Cancer Cell, “Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin.”
1of
6
Innovation in Psychiatry
Neuroscience Advances in Motion is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in psychiatry, neurology and neurosurgery.